Morgan Stanley’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $251M | Buy |
770,968
+129,203
| +20% | +$42.1M | 0.02% | 754 |
|
2025
Q1 | $173M | Sell |
641,765
-85,459
| -12% | -$23.1M | 0.01% | 922 |
|
2024
Q4 | $171M | Buy |
727,224
+108,661
| +18% | +$25.6M | 0.01% | 919 |
|
2024
Q3 | $170M | Sell |
618,563
-122,951
| -17% | -$33.8M | 0.01% | 914 |
|
2024
Q2 | $180M | Buy |
741,514
+66,233
| +10% | +$16.1M | 0.01% | 859 |
|
2024
Q1 | $101M | Sell |
675,281
-937,909
| -58% | -$140M | 0.01% | 1186 |
|
2023
Q4 | $309M | Buy |
1,613,190
+403,807
| +33% | +$77.3M | 0.01% | 891 |
|
2023
Q3 | $214M | Sell |
1,209,383
-671,423
| -36% | -$119M | 0.02% | 663 |
|
2023
Q2 | $357M | Buy |
1,880,806
+649,991
| +53% | +$123M | 0.04% | 490 |
|
2023
Q1 | $247M | Sell |
1,230,815
-159,825
| -11% | -$32M | 0.03% | 621 |
|
2022
Q4 | $330M | Sell |
1,390,640
-108,119
| -7% | -$25.7M | 0.04% | 488 |
|
2022
Q3 | $300M | Buy |
1,498,759
+370,144
| +33% | +$74.1M | 0.04% | 437 |
|
2022
Q2 | $165M | Buy |
1,128,615
+279,958
| +33% | +$40.8M | 0.02% | 677 |
|
2022
Q1 | $139M | Sell |
848,657
-217,032
| -20% | -$35.4M | 0.02% | 677 |
|
2021
Q4 | $181M | Sell |
1,065,689
-815,190
| -43% | -$138M | 0.02% | 606 |
|
2021
Q3 | $355M | Sell |
1,880,879
-1,772
| -0.1% | -$335K | 0.05% | 349 |
|
2021
Q2 | $319M | Buy |
1,882,651
+96,697
| +5% | +$16.4M | 0.04% | 384 |
|
2021
Q1 | $252M | Buy |
1,785,954
+94,114
| +6% | +$13.3M | 0.04% | 416 |
|
2020
Q4 | $220M | Buy |
1,691,840
+171,490
| +11% | +$22.3M | 0.03% | 440 |
|
2020
Q3 | $221M | Buy |
1,520,350
+10,479
| +0.7% | +$1.53M | 0.04% | 354 |
|
2020
Q2 | $224M | Buy |
1,509,871
+124,671
| +9% | +$18.5M | 0.05% | 324 |
|
2020
Q1 | $151M | Sell |
1,385,200
-155,616
| -10% | -$16.9M | 0.04% | 385 |
|
2019
Q4 | $177M | Buy |
1,540,816
+177,298
| +13% | +$20.4M | 0.04% | 405 |
|
2019
Q3 | $110M | Buy |
1,363,518
+26,397
| +2% | +$2.12M | 0.03% | 528 |
|
2019
Q2 | $97M | Buy |
1,337,121
+116,760
| +10% | +$8.47M | 0.03% | 564 |
|
2019
Q1 | $114M | Buy |
1,220,361
+37,462
| +3% | +$3.5M | 0.03% | 498 |
|
2018
Q4 | $86.2M | Sell |
1,182,899
-54,587
| -4% | -$3.98M | 0.03% | 573 |
|
2018
Q3 | $108M | Sell |
1,237,486
-19,556
| -2% | -$1.71M | 0.03% | 570 |
|
2018
Q2 | $124M | Sell |
1,257,042
-3,381
| -0.3% | -$333K | 0.03% | 492 |
|
2018
Q1 | $150M | Buy |
1,260,423
+91,652
| +8% | +$10.9M | 0.04% | 423 |
|
2017
Q4 | $148M | Buy |
1,168,771
+188,948
| +19% | +$24M | 0.04% | 446 |
|
2017
Q3 | $115M | Sell |
979,823
-37,708
| -4% | -$4.43M | 0.03% | 499 |
|
2017
Q2 | $81.2M | Buy |
1,017,531
+315,795
| +45% | +$25.2M | 0.02% | 660 |
|
2017
Q1 | $36M | Sell |
701,736
-110,448
| -14% | -$5.66M | 0.01% | 1118 |
|
2016
Q4 | $30.4M | Sell |
812,184
-28,228
| -3% | -$1.06M | 0.01% | 1190 |
|
2016
Q3 | $57M | Sell |
840,412
-34,692
| -4% | -$2.35M | 0.02% | 775 |
|
2016
Q2 | $48.6M | Sell |
875,104
-203,778
| -19% | -$11.3M | 0.02% | 813 |
|
2016
Q1 | $67.7M | Sell |
1,078,882
-18,043
| -2% | -$1.13M | 0.03% | 617 |
|
2015
Q4 | $103M | Sell |
1,096,925
-115,371
| -10% | -$10.9M | 0.04% | 474 |
|
2015
Q3 | $97.4M | Sell |
1,212,296
-84,961
| -7% | -$6.83M | 0.04% | 479 |
|
2015
Q2 | $156M | Sell |
1,297,257
-102,268
| -7% | -$12.3M | 0.05% | 379 |
|
2015
Q1 | $146M | Buy |
1,399,525
+24,119
| +2% | +$2.52M | 0.05% | 375 |
|
2014
Q4 | $133M | Buy |
1,375,406
+513,571
| +60% | +$49.8M | 0.05% | 417 |
|
2014
Q3 | $67.3M | Sell |
861,835
-5,784
| -0.7% | -$452K | 0.03% | 685 |
|
2014
Q2 | $54.8M | Buy |
867,619
+128,433
| +17% | +$8.11M | 0.02% | 751 |
|
2014
Q1 | $49.6M | Sell |
739,186
-2,379
| -0.3% | -$160K | 0.02% | 747 |
|
2013
Q4 | $47.7M | Buy |
741,565
+550,847
| +289% | +$35.4M | 0.02% | 760 |
|
2013
Q3 | $12.2M | Buy |
190,718
+137,477
| +258% | +$8.8M | 0.01% | 1609 |
|
2013
Q2 | $1.65M | Buy |
+53,241
| New | +$1.65M | ﹤0.01% | 3313 |
|